Glepark belongs to a class of medicines called dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of dopamine receptors triggers nerve impulses in the brain that help to control body movements. Glepark is used to treat symptoms of Parkinson’s disease. It can be used alone or in combination with levodopa (another medicine for Parkinson’s disease).
Dosage form: 0,088 mg tablet, 0,18 mg tablet, 0,35 mg tablet, 0,7 mg tablet
Original product: Sifrol
Markets: Denmark and Finland
ATC Code: N04BC05